657
Participants
Start Date
November 11, 2015
Primary Completion Date
May 12, 2017
Study Completion Date
July 5, 2021
DTG
50 mg tablets administered orally, once daily
F/TAF
200/25 mg tablets administered orally, once daily
B/F/TAF
50/200/25 milligrams (mg) FDC tablets administered orally, once daily
DTG Placebo
Tablets administered orally, once daily
F/TAF Placebo
Tablets administered orally, once daily
B/F/TAF Placebo
Tablets administered orally, once daily
Antwerp
Melbourne
Alicante
Carlton
Prahran
Clayton
Prahran Market Clinic, Prahran
New York
Santo Domingo
The Bronx
Manhasset
Berlin
Albany
Allegheny Health Network, Pittsburgh
Philadelphia
Philadelphia
Washington D.C.
Washington D.C.
Washington D.C.
Milan
Hamburg
Sinai Hospital of Baltimore, Baltimore
Bergamo
Winston-Salem
Cone Health Regional Center for Infectious Disease, Greensboro
Chapel Hill
Madrid
Hospital Universitario Ramon y Cajal, Madrid
Madrid
Madrid
Huntersville
Charlotte
Málaga
Decatur
Atlanta
Atlanta
Macon
Savannah
Pensacola
DeLand
Orlando
Miami
Miami
Miami Beach
Oakland Park
Fort Lauderdale
West Palm Beach
Tampa
Montpellier
Ft. Pierce
Vigo
Düsseldorf
Essen
Cincinnati
Indianapolis
Berkley
Detroit
Uniklinik Köln, Cologne
Tourcoing
Tourcoing
Frankfurt
Frankfurt
Chicago
Chicago
St Louis
St Louis
Kansas City
Dallas
AIDS Arms Inc, Dallas
Dallas
North Texas Infectious Diseases Consultants PA, Dallas
Longview
Fort Worth
Houston
Houston
Bellaire
Austin
Denver
München
Phoenix
Phoenix
Los Angeles
Los Angeles
Los Angeles
Los Angeles
Beverly Hills
Optimus Medical - ClinEdge - PPDS, San Francisco
Kaiser Permanente, San Leandro
Sacramento
Sacramento
Seattle
Spokane
Boston
Boston
Springfield
Hillsborough
Newark
New York
Greenville
Columbia
Annandale
Sydney
Ghent
McGill University Health Center, Montreal
Ottawa
Sunnybrook Health Sciences Centre, Toronto
Toronto
Toronto
Winnipeg
CHU de Nice Archet I, Nice
Roma
San Juan
San Juan
Badalona
Birmingham
Birmingham
London
London
London
London
Chelsea and Westminster NHS Trust, London
St George's Healthcare NHS Trust, London
London
Manchester
Manchester
Lead Sponsor
Gilead Sciences
INDUSTRY